For the past two decades John Gillen has dedicated his life to exploring the latest NAD+ (Nicotinamide Adenine Dinucleotide) therapies, delivering cutting-edge treatments to the UK and across Europe.
For the past two decades John Gillen has dedicated his life to exploring the latest NAD+ (Nicotinamide Adenine Dinucleotide) therapies, delivering cutting-edge treatments to the UK and across Europe.
A true pioneer in the quest for innovative therapies for mental wellness and addiction recovery, John prides himself on working with the very best medical professionals in the field, with the purpose of providing game-changing treatments to those in need.
John’s latest venture sees him the opening of the brand new Eula’s Clinic in Scotland, specialising in offering ground-breaking scientifically backed psychedelic-assisted psychotherapy treatment.
The driving force behind our company's vision and mission
Registered Manager / Director
Sean has over 10 years’ experience in the field, during this time he has been an integral part of various services management structure.
Learn More
Medical Director
Pamela is our MD and consultant psychiatrist, offering extensive experience and expertise in general adult, addiction and forensic psychiatry.
Learn More
Discover the ways in which psychedelic therapy can help in treating depression and anxiety.
Read more
Discover more about a new clinical trial underway in the UK that explores the effectiveness of using ketamine to treat serious alcohol addictions.
Read more